Can Hydrocortisone Improve Patient Outcomes from Septic Shock?
In sepsis cases, hydrocortisone is found to decrease the need for blood pressure-raising drugs and improves survival when used in combination with other corticosteroids.

University of California San Francisco
Give to UCSFIn sepsis cases, hydrocortisone is found to decrease the need for blood pressure-raising drugs and improves survival when used in combination with other corticosteroids.
UCSF scientists have found that brain cancer glioblastoma can cause cognitive decline by affecting neural connections, but the epilepsy drug gabapentin shows promise in blocking this activity, offering hope for new treatments.
Transgender women keep their prostates even after gender-affirming surgery, and the estimated risk of prostate cancer is at about 14 cases per 10,000 people.
UCSF Health’s surgical oncology team is a Bay Area leader in an innovative chemotherapy infusion pump used to treat patients with widely metastatic colorectal and bile duct cancers that have spread to the liver and are no longer considered operable.
UCSF's Division of Surgical Oncology is currently the only center in Northern California offering surgical insertion of hepatic artery infusion (HAI) for patients.
Leading cancer researchers from UCSF will present at this year’s annual meeting of the American Association for Cancer Research (AACR) conference, held April 14-19, 2023, in Orlando.
After more than a decade, Jaime Sepúlveda will step down from his role as executive director of UCSF’s Institute for Global Health Sciences in August 2023.
Pregnant women have a lower risk of gestational diabetes and unhealthy weight gain in cities that tax sugary drinks, according to a first-of-its-kind study of more than 5 million women by UCSF.
Thermo Fisher Scientific Inc. and UCSF will accelerate advanced cell therapies for difficult to treat conditions like cancer from a new manufacturing facility.
A clinical trial showed that, rather than removing lymph nodes, leaving them intact could help immunotherapy activate tumor-fighting T cells in the lymph nodes.
For the past 30 years, the California Tobacco Control Program has helped Californians save $816 billion in health care costs.
A new digital tool helps to calculate breast cancer risk for those who may develop advanced cancer that goes undiagnosed despite regular screenings.
Sick leave coverage expansion were associated with higher rates of mammography screening and colorectal screening, potentially leading to better health outcomes.
Kevin Shokat, who developed a successful approach to drugging a protein produced by the KRAS gene, has received two prestigious scientific awards.
The WISDOM 2.0 study aims to transform breast cancer screening by using a personalized approach and will expand to women as young as 30.
Balyn Zaro’s lab investigates the cause and consequence of genetic diversity in the immune system, in hopes that her discoveries can lead to better treatments for all patients.
A new digital tool helps calculate breast cancer risk for those who may develop advanced cancer that goes undiagnosed despite regular screenings.
Trillions of invisible organisms make up the human microbiome. Now, medical scientists want to put these bugs to work.
On the operating table and inside the lab of a rising star in cancer neurosurgery.
Resecting brain tumors called gliomas as much as possible soon after diagnosis offers a distinct survival advantage when looking at the disease trajectory 10 years later, find UCSF researchers.
Researchers have discovered a cellular uptake pathway for larger molecules that delivers cell-permeable drugs efficiently.
Through decades of biobanking at UCSF, researchers were able to comprehensively map intra-cellular signaling in the cells of recurrent glioblastoma, identifying novel cell-extrinsic therapeutic targets.
T-cells can be directed to produce cytokine, a powerful anti-cancer component, when they encounter cancer cells. This holds tremendous promise for cancer immunotherapy.
UCSF experts in multiple myeloma and other hematologic malignancies will attend the American Society of Hematology’s (ASH) 64th Annual Meeting and Exposition.
A new sophisticated machine learning technique using a molecular library of commands guides engineered immune cells to seek out and tirelessly kill cancer cells.
Since March 2020, UCSF has partnered with government and community groups to address racial, economic and cultural barriers to provide equitable care to vulnerable people during the COVID-19 pandemic.
UCSF breast cancer experts will present new research and clinical findings at the annual San Antonio Breast Cancer Symposium, the largest and most prestigious breast cancer conference.